BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8681447)

  • 1. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.
    Pereira MA; Grubbs CJ; Barnes LH; Li H; Olson GR; Eto I; Juliana M; Whitaker LM; Kelloff GJ; Steele VE; Lubet RA
    Carcinogenesis; 1996 Jun; 17(6):1305-11. PubMed ID: 8681447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats.
    Weisburger JH; Rivenson A; Garr K; Aliaga C
    Cancer Lett; 1997 Mar; 114(1-2):323-7. PubMed ID: 9103322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
    Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
    Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
    Zheng Y; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1999 Feb; 20(2):255-60. PubMed ID: 10069462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.
    Pereira MA; Barnes LH; Steele VE; Kelloff GV; Lubet RA
    Carcinogenesis; 1996 Feb; 17(2):373-6. PubMed ID: 8625466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.
    Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE
    Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of grape seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model.
    Singletary KW; Meline B
    Nutr Cancer; 2001; 39(2):252-8. PubMed ID: 11759289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
    Verma AK; Johnson JA; Gould MN; Tanner MA
    Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons.
    Matsukawa Y; Nishino H; Okuyama Y; Matsui T; Matsumoto T; Matsumura S; Shimizu Y; Sowa Y; Sakai T
    Oncology; 1997; 54(2):118-21. PubMed ID: 9075782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon.
    Delker DA; Papanikolaou A; Suhr YJ; Rosenberg DW
    Chem Biol Interact; 2000 Feb; 124(3):149-60. PubMed ID: 10728775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
    Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
    Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts.
    Baines AT; Holubec H; Basye JL; Thorne P; Bhattacharyya AK; Spallholz J; Shriver B; Cui H; Roe D; Clark LC; Earnest DL; Nelson MA
    Cancer Lett; 2000 Nov; 160(2):193-8. PubMed ID: 11053649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.
    Reddy BS; Rao CV; Rivenson A; Kelloff G
    Carcinogenesis; 1993 Aug; 14(8):1493-7. PubMed ID: 8353834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon.
    Yang K; Lamprecht SA; Liu Y; Shinozaki H; Fan K; Leung D; Newmark H; Steele VE; Kelloff GJ; Lipkin M
    Carcinogenesis; 2000 Sep; 21(9):1655-60. PubMed ID: 10964096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.